Metraipolis › archive › dc_68cd3df6d46d

Development and characterization of ivermectin nanoformulations for topical acaricidal activity against Rhipicephalus sanguineus ticks — Europe PMC PMID:42277232

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42277232
DOI
10.1038/s41598-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-10-31T13:04:34.344Z
SHA-256 of the archived text
de1c1030359dac215b7ceb65ee5f867c2b761aa0620151db3b24370f9933a320
Stable URL of this page
https://metraipolis.com/documento/dc_68cd3df6d46d

How to cite

Development and characterization of ivermectin nanoformulations for topical acaricidal activity against Rhipicephalus sanguineus ticks — Europe PMC PMID:42277232 — Europe PMC (en), https://europepmc.org/article/MED/42277232 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68cd3df6d46d (Metraipolis archive dc_68cd3df6d46d, sha256 de1c1030359dac215b7ceb65ee5f867c2b761aa0620151db3b24370f9933a320)
BibTeX
@misc{dc68cd3df6d46d,
  title = {Development and characterization of ivermectin nanoformulations for topical acaricidal activity against Rhipicephalus sanguineus ticks — Europe PMC PMID:42277232},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42277232},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68cd3df6d46d; sha256 de1c1030359dac215b7ceb65ee5f867c2b761aa0620151db3b24370f9933a320},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42277232. Agents can read the archived copy with the MCP tool read_document.